South Shore Health Emphasizes Early Prostate Cancer Detection for Improved Outcomes
South Shore Health is highlighting the critical importance of early prostate cancer detection, particularly during Men's Health Awareness Month in November 2026. Prostate cancer is the second most common cancer among American men and the second leading cause of cancer death for men. The American Cancer Society (ACS) projects approximately 333,830 new cases and 36,320 deaths from prostate cancer in 2026. While primarily affecting older men (6 in 10 cases diagnosed at 65 or older), incidence rates have risen by 3% annually over the last decade. Radiation oncologist Peter F. Orio, III, DO, and Chief of Urology Sergio D. Fefer, MD, stress that early-stage prostate cancer often presents without symptoms, making routine screening crucial for better treatment options and more favorable outcomes. Screening typically involves periodic PSA-based testing and physical exams, with discussions between patients and clinicians to weigh benefits and harms based on individual risk factors.
